AU2009285667B2 - A DNA replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants - Google Patents

A DNA replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants Download PDF

Info

Publication number
AU2009285667B2
AU2009285667B2 AU2009285667A AU2009285667A AU2009285667B2 AU 2009285667 B2 AU2009285667 B2 AU 2009285667B2 AU 2009285667 A AU2009285667 A AU 2009285667A AU 2009285667 A AU2009285667 A AU 2009285667A AU 2009285667 B2 AU2009285667 B2 AU 2009285667B2
Authority
AU
Australia
Prior art keywords
nucleic acid
acid segment
protein
expression
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2009285667A
Other languages
English (en)
Other versions
AU2009285667A1 (en
Inventor
Charles J. Arntzen
Qiang Chen
Brooke Hjelm
Zhong Huang
Hugh S. Mason
Shuo YUAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arizona State University ASU
Original Assignee
Arizona State University ASU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arizona State University ASU filed Critical Arizona State University ASU
Publication of AU2009285667A1 publication Critical patent/AU2009285667A1/en
Application granted granted Critical
Publication of AU2009285667B2 publication Critical patent/AU2009285667B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2009285667A 2008-08-27 2009-08-27 A DNA replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants Ceased AU2009285667B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9231808P 2008-08-27 2008-08-27
US61/092,318 2008-08-27
PCT/US2009/055237 WO2010025285A1 (en) 2008-08-27 2009-08-27 A dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants

Publications (2)

Publication Number Publication Date
AU2009285667A1 AU2009285667A1 (en) 2010-03-04
AU2009285667B2 true AU2009285667B2 (en) 2015-05-28

Family

ID=41721933

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2009285667A Ceased AU2009285667B2 (en) 2008-08-27 2009-08-27 A DNA replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants

Country Status (7)

Country Link
US (2) US8513397B2 (https=)
EP (1) EP2328401B8 (https=)
JP (1) JP5785080B2 (https=)
AU (1) AU2009285667B2 (https=)
CA (1) CA2736796A1 (https=)
IL (1) IL211388A (https=)
WO (1) WO2010025285A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
WO2009076778A1 (en) 2007-11-27 2009-06-25 Medicago Inc. Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
AU2009267769B2 (en) 2008-07-08 2015-07-16 Medicago Inc. Soluble recombinant influenza antigens
CA2736796A1 (en) 2008-08-27 2010-03-04 Arizona Board Of Regents For And On Behalf Of Arizona State University A dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants
HUE039100T2 (hu) 2009-06-24 2018-12-28 Medicago Inc Hemagglutinint tartalmazó kimer influenzavírus-jellegû részecskék
KR101773431B1 (ko) 2009-09-22 2017-09-12 메디카고 인코포레이티드 식물-유래 ｖｌｐ의 제조방법
WO2012058762A1 (en) 2010-11-04 2012-05-10 Medicago Inc. Plant expression system
TWI526539B (zh) 2010-12-22 2016-03-21 苜蓿股份有限公司 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
KR101963792B1 (ko) 2011-06-13 2019-07-31 메디카고 인코포레이티드 식물에서 광견병 바이러스 유사 입자 생성
NZ622731A (en) 2011-09-30 2016-04-29 Medicago Inc Increasing virus-like particle yield in plants
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
EA032089B1 (ru) 2012-05-11 2019-04-30 Медикаго Инк. Получение ротавирус-подобных частиц в растениях
JP2015528285A (ja) 2012-09-05 2015-09-28 メディカゴ インコーポレイテッド 植物におけるピコルナウイルス様粒子の産生
US10125373B2 (en) * 2013-01-22 2018-11-13 Arizona Board Of Regents On Behalf Of Arizona State University Geminiviral vector for expression of rituximab
ES2803508T3 (es) 2013-03-28 2021-01-27 Medicago Inc Producción de partículas similares al virus de la gripe en plantas
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
RU2731295C2 (ru) 2014-07-11 2020-09-01 Медикаго Инк. Модификация продуцирования белков в растениях
US9340604B1 (en) 2014-10-29 2016-05-17 Aridis Pharmaceuticals, Inc. Human monoclonal antibody specific for the F protein of respiratory syncytial virus (RSV)
WO2016079739A2 (en) * 2014-11-20 2016-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
US11078491B2 (en) 2017-05-24 2021-08-03 Arizona Board Of Regents On Behalf Of Arizona State University Vaccines against Zika virus based on Zika structure proteins
US11130956B2 (en) 2017-06-05 2021-09-28 Arizona Board Of Regents On Behalf Of Arizona State University Reducing the toxicity of agrobacterium endotoxin
US12297443B2 (en) * 2018-03-02 2025-05-13 Arizona Board Of Regents On Behalf Of Arizona State University Optimized plant expression systems
US11058766B2 (en) 2018-05-04 2021-07-13 Arizona Board Of Regents On Behalf Of Arizona State University Universal vaccine platform
US12466862B2 (en) * 2019-06-04 2025-11-11 Arizona Board Of Regents On Behalf Of Arizona State University Plant-produced mABs against chikungunya virus with enhanced effector function and efficacy
WO2022260849A1 (en) 2021-06-09 2022-12-15 Nant Holdings Ip, Llc Methods and systems for producing a protein of interest in a plant
US20240417698A1 (en) * 2021-11-01 2024-12-19 Arizona Board Of Regents On Behalf Of Arizona State University A method for production of self-replicating, nucleic acid-loaded, virus-like particles (vlp-na) and the uses thereof
WO2024097732A2 (en) * 2022-11-01 2024-05-10 Arizona Board Of Regents On Behalf Of Arizona State University A method for production of self-replicating, nucleic acid-loaded, virus-like particles (vlp-na) and the uses thereof
WO2025019375A2 (en) * 2023-07-14 2025-01-23 Inari Argiculture Technology, Inc. Replicons for precise genome editing in plants

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030079248A1 (en) * 1998-10-07 2003-04-24 Hugh Mason Gemini virus vectors for gene expression in plants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030004305A (ko) * 1999-11-22 2003-01-14 플랜트 바이오사이언스 리미티드 전사 후 유전자 사일런싱（ｐｔｇｓ）의 억제제와 함께발현시킴으로써 이식 유전자의 발현을 증가시키는 방법
ATE530654T1 (de) * 2001-07-06 2011-11-15 Monsanto Technology Llc Verfahren zur förderung der aufspaltung von transgenen bei pflanzen und zusammensetzungen dafür
US20040170606A1 (en) * 2002-06-07 2004-09-02 Palmer Kenneth E. Production of peptides in plants as viral coat protein fusions
US7618815B2 (en) * 2006-03-08 2009-11-17 University Of Kentucky Research Foundation Viral vectors useful in soybean and methods of use
CA2736796A1 (en) 2008-08-27 2010-03-04 Arizona Board Of Regents For And On Behalf Of Arizona State University A dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants
US10125373B2 (en) 2013-01-22 2018-11-13 Arizona Board Of Regents On Behalf Of Arizona State University Geminiviral vector for expression of rituximab

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030079248A1 (en) * 1998-10-07 2003-04-24 Hugh Mason Gemini virus vectors for gene expression in plants

Also Published As

Publication number Publication date
EP2328401A1 (en) 2011-06-08
US8513397B2 (en) 2013-08-20
JP2012501182A (ja) 2012-01-19
IL211388A (en) 2016-09-29
CA2736796A1 (en) 2010-03-04
IL211388A0 (en) 2011-05-31
AU2009285667A1 (en) 2010-03-04
US20140141515A1 (en) 2014-05-22
US9506079B2 (en) 2016-11-29
EP2328401B1 (en) 2017-02-08
JP5785080B2 (ja) 2015-09-24
WO2010025285A1 (en) 2010-03-04
US20110262966A1 (en) 2011-10-27
EP2328401A4 (en) 2012-07-11
EP2328401B8 (en) 2017-04-19

Similar Documents

Publication Publication Date Title
AU2009285667B2 (en) A DNA replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants
US10125373B2 (en) Geminiviral vector for expression of rituximab
Maclean et al. Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization
US9017987B2 (en) Expression of proteins in plants
US6800748B2 (en) Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
KR102162118B1 (ko) 식물에서 로타바이러스-유사 입자 생산
CN102016034B (zh) 细菌毒素疫苗
Soria-Guerra et al. Expression of an HBcAg-based antigen carrying angiotensin II in Chlamydomonas reinhardtii as a candidate hypertension vaccine
Shanmugabalaji et al. Dual targeting of a mature plastoglobulin/fibrillin fusion protein to chloroplast plastoglobules and thylakoids in transplastomic tobacco plants
Mathioudakis et al. Pepino mosaic virus capsid protein interacts with a tomato heat shock protein cognate 70
CN102307995B (zh) 积累疫苗的转化的大豆植物及其用途
US20120174263A1 (en) Production of viral capsids
Shokrian Hajibehzad et al. High-level transient expression of the N-terminal domain of IpaD from Shigella dysenteriae in four plant species transformed with different construct configurations
Ganapathy et al. Immunodiagnostic properties of Wucheraria bancrofti SXP-1, a potential filarial diagnostic candidate expressed in tobacco plant, Nicotiana tabacum
Ayala et al. Production of Plantibodies in Nicotiana plants
WO1999049024A9 (en) Methods and compositions for production of multimeric proteins in transgenic plants
Ofoghi et al. Comparison of tobacco etch virus and tobacco mosaic virus enhancers for expression of human calcitonin gene in transgenic potato plant
Jacobs Enhancement of plant expression vectors using replication and silencing suppressor elements
Campus et al. Chapter Title Oral Rabies Vaccine Design for Expression in Plants Copyright Year 2017 Copyright Holder Springer Science+ Business Media New York Author Family Name Singh Particle
Khalighi Preliminary Assessment of the Effect of Plant Protease Inhibitors on the Expression of Heterologous Genes in Plant Cells

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired